Silence Therapeutics plc (SLN)
NASDAQ: SLN · IEX Real-Time Price · USD
21.25
+0.59 (2.86%)
Apr 16, 2024, 4:00 PM EDT - Market closed

Silence Therapeutics Revenue

In the year 2023, Silence Therapeutics had annual revenue of $32.12M with 52.33% growth. Revenue in the quarter ending December 31, 2023 was $2.66M, a -53.72% decrease year-over-year.

Revenue (ttm)
$32.12M
Revenue Growth
+52.33%
P/S Ratio
30.76
Revenue / Employee
$294,681
Employees
109
Market Cap
988.17M USD

Revenue Chart

* The company reports in GBP currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202332.12M11.03M52.33%
Dec 31, 202221.09M4.53M27.38%
Dec 31, 202116.55M9.05M120.55%
Dec 31, 20207.51M7.18M2,237.77%
Dec 31, 2019321.05K--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BioCryst Pharmaceuticals 331.41M
MiMedx Group 321.48M
Cronos Group 87.24M
Bicycle Therapeutics 26.98M
Abivax 5.13M
Viridian Therapeutics 314.00K
Revenue Rankings